Characterization of cross-resistance to methotrexate in a human breast cancer cell line selected for resistance to melphalan
- 1 April 1995
- journal article
- research article
- Published by Elsevier in Biochemical Pharmacology
- Vol. 49 (8) , 1069-1078
- https://doi.org/10.1016/0006-2952(95)98503-2
Abstract
No abstract availableKeywords
This publication has 23 references indexed in Scilit:
- Decreased melphalan accumulation in a human breast cancer cell line selected for resistance to melphalanBritish Journal of Cancer, 1993
- Stable transfectants of human MCF-7 breast cancer cells with increased levels of the human folate receptor exhibit an increased sensitivity to antifolates.Journal of Clinical Investigation, 1993
- New Colorimetric Cytotoxicity Assay for Anticancer-Drug ScreeningJNCI Journal of the National Cancer Institute, 1990
- Role of amino acid transport and countertransport in nutrition and metabolism.Physiological Reviews, 1990
- Mammalian folylpoly-.gamma.-glutamate synthetase. 1. Purification and general properties of the hog liver enzymeBiochemistry, 1987
- Intracellular pharmacokinetics of methotrexate polyglutamates in human breast cancer cells. Selective retention and less dissociable binding of 4-NH2-10-CH3-pteroylglutamate4 and 4-NH2-10-CH3-pteroylglutamate5 to dihydrofolate reductase.Journal of Clinical Investigation, 1983
- Synthesis, Retention, and Biological Activity of Methotrexate Polyglutamates in Cultured Human Breast Cancer CellsJournal of Clinical Investigation, 1982
- A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye bindingAnalytical Biochemistry, 1976
- Cleavage of Structural Proteins during the Assembly of the Head of Bacteriophage T4Nature, 1970
- An Isotopic Assay for Thymidylate Synthetase*Biochemistry, 1966